Literature DB >> 12032838

Identification and characterization of regulatory elements of the human prostatic acid phosphatase promoter.

Stanislav Zelivianski1, Tsukasa Igawa, Stephen Lim, Rodney Taylor, Ming-Fong Lin.   

Abstract

Human prostatic acid phosphatase (PAcP) is a prostate epithelium-specific differentiation antigen. The cellular form of PAcP functions as a neutral protein-tyrosine phosphatase, and is involved in regulating prostate cell growth. Although some information on the PAcP gene structure has been obtained, little is known regarding the cis- and trans-acting factors that regulate its expression. Due to the biological importance of PAcP, we investigated the regulation of its expression. A region upstream of the PAcP gene from -2899 to +87 base pairs was linked to the coding sequence of the chloramphenicol acetyltransferase (CAT) gene. Sequential deletions of the sequence between -2899 and -205 revealed that, in addition to the basic promoter, the region between -1258 and -779 represents a positive regulatory element. This -1258/-779 fragment could enhance the PAcP promoter activity in PC-3 and DU 145 human prostate cancer cells, but not in non-prostate cancer cells, including WI-38 lung diploid cells, A-431 epidermoid carcinoma cells, and HeLa cervix epitheloid carcinoma cells. Furthermore, this cis-element together with the promoter sequence could drive a high level of expression of green fluorescent protein (GFP) in PC-3 cells, but not in HeLa cells. The prostate-specific expression was further examined by injecting naked plasmid DNA into the prostate and the hamstring muscle of mice. The fluorescence pattern clearly showed that the level of GFP expression is consistently higher in prostate cells than in muscle cells of the intact animal. The data collectively indicate that region between -1258 and -779 is involved in governing the cell type-specific expression of the PAcP gene.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12032838     DOI: 10.1038/sj.onc.1205471

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  4 in total

1.  Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells.

Authors:  Yu-Wei Chou; Nagendra K Chaturvedi; Shougiang Ouyang; Fen-Fen Lin; Dharam Kaushik; Jue Wang; Isaac Kim; Ming-Fong Lin
Journal:  Cancer Lett       Date:  2011-07-22       Impact factor: 8.679

2.  Characterization of cis elements of the probasin promoter necessary for prostate-specific gene expression.

Authors:  JianFeng Zhang; Nan Gao; David J DeGraff; Xiuping Yu; Qian Sun; Thomas C Case; Susan Kasper; Robert J Matusik
Journal:  Prostate       Date:  2010-06-15       Impact factor: 4.104

3.  Transcriptional activation of the human prostatic acid phosphatase gene by NF-kappaB via a novel hexanucleotide-binding site.

Authors:  Stanislav Zelivianski; Richard Glowacki; Ming-Fong Lin
Journal:  Nucleic Acids Res       Date:  2004-07-07       Impact factor: 16.971

Review 4.  Human prostatic acid phosphatase: structure, function and regulation.

Authors:  Sakthivel Muniyan; Nagendra K Chaturvedi; Jennifer G Dwyer; Chad A Lagrange; William G Chaney; Ming-Fong Lin
Journal:  Int J Mol Sci       Date:  2013-05-21       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.